CTRI/2025/12/099378尚未招募不适用
To evaluate the safety and efficacy of skin care formulation in terms of Skin moisturization and comparison of treated versus Untreated area on healthy human subjects
Pigeon India Private Limited1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2025年12月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 33
- 试验地点
- 1
研究概览
简要总结
OBJECTIVE:The objective of this study will be to evaluate the in-vivo safety and efficacy of Skin Care Formulation in terms of Skin Moisturization and comparison of treated versus untreated area on healthy human subjects The evaluation is performed using: Subject Self Evaluation (SSE), Dermatological Evaluation: Cosmetic Acceptability, Corneometry
POPULATION:33 female subjects will be selected for this study. The subjects selected for this study will be healthy females aged between 18 to 40 years, having dry skin with corneometer reading <30 on forearms.
STUDY DURATION: 24 Hours following the application of the product.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- Participant and Outcome Assessor Blinded
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Indian female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Subject having dry skin with corneometer reading less than or equal to 30 on forearms.
排除标准
- •Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •Having refused to give her/his assent by not signing the consent form
- •Taking part in another study liable to interfere with this study
- •Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
- •Having a progressive asthma (either under treatment or last fit in the last 2 years)
- •Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
- •Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
- •Being epileptic.
- •Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
- •Having cutaneous hypersensitivity.
- •Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
研究者
Dr Niharika Salian
MASCOT-SPINCONTROL India Pvt. Ltd.
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Study to check the Safety and Effectiveness of a cosmetic product on human volunteersCTRI/2026/01/102300Vedistry Pvt Ltd.36
尚未招募
不适用
Study to check the effect of product on skin pores.CTRI/2026/03/105462Naturis Cosmetics Pvt. Ltd.36
尚未招募
不适用
Evaluation of Safety and Hair Removal Effect of a Skin Care ProductCTRI/2026/01/101009RG Biocosmetics33
尚未招募
不适用
Study on the Safety and Effectiveness of a cosmetic productCTRI/2026/01/101439Amvigor Organics Pvt Ltd72
尚未招募
不适用
Study to assess the safety and effectiveness of the product on human volunteersCTRI/2025/08/093104Multani Pharmaceuticals Limited36